Experimental and clinical psychopharmacology
-
Exp Clin Psychopharmacol · Apr 2012
Drinking to distraction: does alcohol increase attentional bias in adults with ADHD?
Previous research has shown that social drinkers continue to show attentional bias toward alcohol-related stimuli even after consuming a moderate dose of alcohol. In contrast, little is known about how alcohol acutely affects attentional bias in groups at risk to develop alcohol-related problems, such as adults with attention-deficit/hyperactivity disorder (ADHD). Such individuals may show increased attentional bias following alcohol relative to nonclinical controls. ⋯ This relation was observed only in the ADHD group. These findings indicate that an acute alcohol dose increases attentional bias in adults with ADHD. Further, attentional bias appears to be a predictor of ad libitum consumption in this group.
-
Exp Clin Psychopharmacol · Apr 2012
Randomized Controlled TrialEgo depletion increases ad-lib alcohol consumption: investigating cognitive mediators and moderators.
When self-control resources are depleted ("ego depletion"), alcohol-seeking behavior becomes closely associated with automatic alcohol-related processing biases (e.g., Ostafin, Marlatt, & Greenwald, 2008). The current study aimed to replicate and extend these findings, and also to investigate whether the effects of ego depletion on drinking behavior would be mediated by temporary impairments in executive function or increases in impulsivity. Eighty heavy social drinkers (46 female) initially completed measures of automatic approach tendencies (stimulus response compatibility [SRC] task) and attentional bias (visual probe task) elicited by alcohol-related cues. ⋯ Ego depletion had inconsistent effects on measures of executive function and impulsivity, and none of these measures mediated the effect of ego depletion on ad-lib drinking. However, the effect of ego depletion on ad-lib drinking was mediated by self-reported effort in suppressing emotion and thoughts during the manipulation. Implications for the effects of self-control strength on drinking behavior, and cognitive mediators of these effects, are discussed.
-
Exp Clin Psychopharmacol · Dec 2010
Randomized Controlled TrialThe effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
The cognitive benefits of modafinil to patients undergoing 7-day inpatient withdrawal from methamphetamine (MA) dependence were examined as part of a double-blind, randomized, placebo-controlled pilot trial. Recent evidence has identified modafinil-related improvements in treatment outcomes for MA-dependent patients; however, the benefits to cognition function, which is critical to treatment success but known to be impaired, has yet to be examined. The first 20 participants recruited to the study were administered either 200 mg of modafinil (once daily) or placebo, and a neuropsychological test battery (including an MA version of the emotional Stroop task) at admission (n = 17) and discharge (n = 14). ⋯ All participants showed a significant attentional bias for MA-related stimuli on the emotional Stroop task. The magnitude of bias predicted both retention in treatment and relapse potential at follow-up but was not significantly ameliorated by modafinil treatment. While nonsignificant, the effect sizes of modafinil-related improvements in executive function and memory were consistent with those found in more robustly powered studies of cognitive benefits in attention-deficit/hyperactivity disorder and schizophrenia, supporting the need for further research.
-
Exp Clin Psychopharmacol · Aug 2010
Repeated administration of pioglitazone attenuates development of hyperalgesia in a rat model of neuropathic pain.
Recent studies indicate the central neuroimmune and neuroinflammation activation play a critical role in the pathological states of pain. Pioglitazone, a potent synthetic agonists of PPARgamma, has shown to control neuroinflammation in many nervous system-related disorders. The present study was designed to explore the effects of pioglitazone in treating neuropathic pain and its possible neuroimmune mechanisms in the neuropathic pain using lumbar 5 (L5) spinal nerve transection rat model. ⋯ We found that pioglitazone (5 and 10 mg/kg) can markedly attenuate mechanical hyperalgesia produced by nerve transection, most significantly on the 14th day. The elevated TNF-alpha, IL-1beta, and NF-kappaB in brain were accordingly reduced. Our data could conclude that pioglitazone has ameliorative potential in attenuating the painful state associated with L5 nerve transection, which may further be attributed to inhibiting cerebral proinflammatory cytokines production and NF-kappaB activation in central nervous system.
-
Exp Clin Psychopharmacol · Jun 2010
Randomized Controlled Trial Clinical TrialDifferential effect of codeine on thermal nociceptive sensitivity in sleepy versus nonsleepy healthy subjects.
Basal sleepiness-alertness modulates drug effects. Sleepiness produced by sleep restriction leads to increased nociceptive sensitivity, suggesting opioid analgesia may also be modulated by sleepiness-alertness. This study compared thermal nociceptive sensitivity in sleepy versus nonsleepy participants after codeine or placebo. ⋯ More important, there was a Group x Drug interaction with codeine increasing FWL in the nonsleepy, but not the sleepy, group. These data show the analgesic effects of codeine are diminished in sleepy versus nonsleepy individuals. They suggest clinical differences in response to analgesics are partly explained by basal state of sleepiness-alertness.